Riskpilot← Back to searchSign inGet full accessXEli AB
ABActiveOrg 5569228868Källarlyckevägen 6Medical specialists activities · NACE 8622Est. 20130 employees
Revenue 2025
SEK 487K
-11% vs 2024
EBITDA margin
88.3%
-14% vs 2024
Equity ratio
51.7%
Financial strength
Net profit 2025
SEK 259K
-14% vs 2024
| Revenue | SEK 487K | -11% |
| EBITDA | SEK 430K | -14% |
| Net profit | SEK 259K | -14% |
| Total assets | SEK 602K | +12% |
| Equity | SEK 311K | -12% |
| Employees | 0 | — |
Legal name
XEli AB
Org number
5569228868
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 februari 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva analys av röntgenbilder och avge en medicinsk rapport, medicinsk konsultverksamhet och därmed förenlig verksamhet samt äga och förvalta lös och fast egendom.
Address
Källarlyckevägen 6
Email
elisabeth.im.nilsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 226 | 293 | 548 | 487 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −11 | 196 | 264 | 498 | 430 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −11 | 196 | 264 | 498 | 430 |
| Net financials | — | — | 3 | 5 | 2 |
| Profit before tax | −11 | 196 | 267 | 379 | 327 |
| Tax | −0 | −36 | −55 | −78 | −68 |
| Net profit | −11 | 160 | 212 | 301 | 259 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 89 | 255 | 288 | 538 | 602 |
| Equity | 52 | 212 | 264 | 352 | 311 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 37 | 43 | 24 | 62 | 62 |
| Total debt | 37 | 43 | 24 | 62 | 62 |
EBITDA margin
88.3%
This company
15.8%
Market median
+459% vs market
20212025
Equity ratio
51.7%
This company
38.2%
Market median
+35% vs market
20212025
Return on equity
83.3%
This company
18.4%
Market median
+353% vs market
20212025
Net profit margin
53.2%
This company
8.1%
Market median
+557% vs market
20212025
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20212025
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of XEli AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elisabeth Inger Marie Nilsson | Board of Directors | 0 companies |
| Olof Viking Harrysson | Deputy Board Member | 0 companies |